Recombinant anti-bovine serum

The University of Nebraska Medical Center, a state institution operating under the Board of Regents of the University of Nebraska, issued Purchase Order 4800205155 to Fisher Scientific Co LLC on May 26, 2026, for the procurement of recombinant anti-bovine serum. The contract, valued at $486, encompasses a single unit of the specialized biological reagent (material number NC1675214) required for medical research or diagnostic purposes. Fisher Scientific Co LLC, based in Chicago, Illinois, serves as the prime contractor for this acquisition.

Performance under this purchase order was scheduled for immediate fulfillment, with delivery required by May 27, 2026, to the University of Nebraska Medical Center General Supply facility located at 601 South Saddle Creek Road in Omaha, Nebraska. The contract terms include Net 30 payment provisions with discount incentives for prompt payment, free on board destination shipping with prepaid freight, and a requirement for vendor acknowledgment within ten days of order issuance. All invoices and supporting documentation must reference the purchase order number to facilitate processing and record-keeping.